Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-human trial supports benefits of BKT-140 in autologous transplantation for multiple myeloma

Dec. 10, 2010

CUDC-101 shows good tolerability in first-in-human trial in advanced solid tumors

Dec. 10, 2010

Phase I data presented on volociximab/ranibizumab combination in wet AMD

Dec. 10, 2010

Development of cancer stem cell-targeting agents SL-401 and SL-501 continues

Dec. 10, 2010

ArQule evaluates ARQ-087 in models of cancer

Dec. 9, 2010

ACT Biotech describes unique mechanism of action of ACTB-1003

Dec. 9, 2010

BI-6727 shows promise in phase I/II trial in acute myeloid leukemia

Dec. 9, 2010

Phase I/II data presented on MLN-8237 in hematological malignancies

Dec. 9, 2010

Phase II results for plitidepsin in peripheral T-cell lymphoma presented

Dec. 7, 2010

Activity seen with ARRY-520 in patients with relapsed/refractory multiple myeloma

Dec. 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...